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Method
Biome representational in silico karyotyping
Valliammai Muthappan,1,2,7 Aaron Y. Lee,1,7 Tamara L. Lamprecht,1,2
Lakshmi Akileswaran,2 Suzanne M. Dintzis,3 Choli Lee,4 Vincent Magrini,5
Elaine R. Mardis,5 Jay Shendure,4 and Russell N. Van Gelder1,2,6,8
1Department of Ophthalmology and Visual Science, Washington University, St. Louis, Missouri 63110, USA; 2Department
of Ophthalmology, University of Washington, Seattle, Washington 98195, USA; 3Department of Pathology, University of Washington,
Seattle, Washington 98195, USA; 4Department of Genomic Sciences, University of Washington, Seattle, Washington 98195, USA;
5Department of Genetics, Washington University, St. Louis, Missouri 63110, USA; 6Department of Biological Structure, University
of Washington, Seattle, Washington 98195, USA
Metagenomic characterization of complex biomes remains challenging. Here we describe a modification of digital
karyotyping—biome representational in silico karyotyping (BRISK)—as a general technique for analyzing a defined
representation of all DNA present in a sample. BRISK utilizes a Type IIB DNA restriction enzyme to create a defined
representation of 27-mer DNAs in a sample. Massively parallel sequencing of this representation allows for con-
struction of high-resolution karyotypes and identification of multiple species within a biome. Application to normal
human tissue demonstrated linear recovery of tags by chromosome. We apply this technique to the biome of the oral
mucosa and find that greater than 25% of recovered DNA is nonhuman. DNA from 41 microbial species could be
identified from oral mucosa of two subjects. Of recovered nonhuman sequences, fewer than 30% are currently
annotated. We characterized seven prevalent unknown sequences by chromosome walking and find these represent
novel microbial sequences including two likely derived from novel phage genomes. Application of BRISK to archival
tissue from a nasopharyngeal carcinoma resulted in identification of Epstein-Barr virus infection. These results
suggest that BRISK is a powerful technique for the analysis of complex microbiomes and potentially for pathogen
discovery.
[Supplemental material is available for this article. The sequencing data from this study have been submitted to GenBank
(http://www.ncbi.nlm.nih.gov/Genbank/) under accession nos. FI185049.1, FI185051.1, FI185052.1, FI185053.1, FI185054.1,
and FI185056.1.]
The human body is a complex biome which includes trillions of
individual genomes of thousands of microbial species (Kurokawa
et al. 2007; Turnbaugh et al. 2007; Lampe 2008; Turnbaugh et al.
2009). Within the body are several characterized microbiomes, in-
cluding that of the distal gut (Eckburg et al. 2005; Qin et al. 2010),
vaginal mucosa (Oakley et al. 2008; Fredricks et al. 2009), oral mu-
cosa (Aas et al. 2005; Keijser et al. 2008; Nasidze et al. 2009a; Nasidze
et al. 2009b; Zaura et al. 2009), skin (Costello et al. 2009; Grice et al.
2009), and conjunctiva (Graham et al. 2007).While saturation deep
sequencing of a complex biome is the theoretical gold standard for
its characterization (Venter et al. 2004;Williamson et al. 2008), such
an approach is not yet economical or practical for clinical samples
and is very computationally intensive. Human microbiomes have
been primarily characterized by 16S ribosomal sequencing for bac-
terial DNA, and to a lesser extent, by 18S and internal transcribed
spacer (ITS) ribosomal sequencing for fungal DNA, but these tech-
niques are not readily adaptable to viruses, phage, or parasites.
Several digital karyotyping methods have been used to char-
acterize defined genomic representations (Wang et al. 2002b; Tengs
et al. 2004; Leary et al. 2007). These are capable of generating high
resolution karyotypes ofhumanDNA inanalyzed samples, aswell as
identifying foreign DNA within the sample. However, their use to
date has largely been restricted to human tissue, with only a single
report of digital karyotyping to characterize nonhumanDNAwithin
cancer specimens (Duncan et al. 2009).
Here we describe biome representational in silico karyotyping
(BRISK), which subjects a biome’s genomic representation generated
by aType IIB restriction endonuclease (Tengs et al. 2004) tomassively
parallel deep sequencing. We demonstrate that many known and
novel microbial sequences may be readily identified in the resulting
metagenomic karyotype.
Results
Overview of the BRISK technique
A schematic of the BRISK technique is shown in Figure 1. A Type IIB
restriction endonuclease (BsaXI) with a 6-bp recognition sequenc-
ing yielding a 33-bp restriction fragment (27 bp double-stranded
with two 3-bp single-stranded overhangs) is used to generate the
representation. Asymmetric adaptor sequences designed to interface
directly with the Illumina high-throughput sequencing method
(Bentley et al. 2008) are ligated to the digested DNA; one adaptor is
additionally biotinylated on the 59 end. The ligation products are
bound to a streptavidin column, gaps are repaired with a nick-
translating DNA polymerase, and the desired products (those hav-
ing different adaptors on each end) are melted off the column and
captured. Following polymerase chain reaction-mediated amplifi-
cation, the representation is directly applied to the Illumina se-
quencing platform.
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The bioinformatic analysis of sequence data is summarized in
Figure 2. After sequencing, 27 bp of sequence (the double-stranded
portion of the representation) is parsed and matched against an
SQL database containing all tags resulting from a virtual BsaXI
digest of all sequences from GeneBank divisions of primates, bac-
teria, invertebrates, fungi, plants, phages, and viruses (GenBank
Release 178.0). In silico digestion of the reference human genome
with BsaXI yields 1.3 million fragments of which 1.1 million are
unique sequences. Tags matching human DNA are mapped to po-
sition, forming a karyotypewith;4-kb resolution. Virtual digestion
of bacterial, fungal, plant, and viral sequences yields 2.4 million
sequence tags. Of these, only 418 tags (0.02%) are found in both
human and microbial/fungal/viral databases. These tags were not
used for assignment.
Matches to microbial and viral sequences are then tallied.
Microbial and viral tags are assorted in the database to two cate-
gories: unique, and ambiguous. A unique tag is found only in a single
species. Ambiguous tags are found in more than one organism (for
instance, between two or more species of one genus). Of the 1.7
million tags in the bacterial and viral data set, 1.2million are unique
(68.6%). A ‘‘unique’’ score for each microbial or viral species is
calculated based on the number of sequenced tags that are unique
matches for that organism. A global score is calculated for each
species as well, which is a sum of the unique score and a fractional
score for each ambiguous tag (for instance, a tag appearing once
matching five species would weight 0.2 for any specific species).
Scores are generated for each microbe or virus. To be assigned as
‘‘present’’, an empirical criterion of recovery of at least two, inde-
pendent, unique tags for that organism is applied.
To analyze the remaining (unmatched) tags, a Levenshtein edit
distancemodel is employed (Yujian and Bo 2007). Empirical analysis
of human and microbial tags within the database reveals that fewer
than 0.086% of human tags are within 3 Levenshtein edit distances
(e.g., single base changes, additions, or deletions) of the nearest mi-
crobial 27-mer tag. The average human sequence is 6.5 edit distances
from the closestmicrobial tag. Tags greater than 3 edit distances from
the nearest human match, but not matching any tags in the mi-
crobial or viral databases, are taken to represent potentially novel
sequences and are subjected to further analysis.
Application to digital karyotyping
We initially characterized the digital karyotyping capabilities of
BRISK by analyzing the digital karyotype of an aseptically acquired
human blood sample. Starting from 3 mg of genomic DNA, a total of
12,529,752 tags were identified from the human blood sample
(Table 1). Of these, 11,844,721 (95%) were perfect matches to tags
in the human database. Of the 324,592 nonmatching distinct tags,
44,785 were found in other aseptically obtained human blood or
human cell line samples, suggesting that these are polymorphic or
undocumented human sequences. An additional 199,016 tags
were within 3 Levenstein edit distances of nearest human
match, again suggesting either polymorphic human sequence or
Figure 1. (A) Schematic of BRISK technique. (B) Representative ethidium bromide-stained agarose gel of BRISK products. (Lane 1) 1 kb DNA ladder;
(lane 2) 100 bp DNA ladder; (lane 3) PCR amplification of BRISK fragments following ligation of asymmetric adaptors; (lane 4) amplification of unbound
material from biotin column; (lane 5) amplification of beads following melt and elution of single-stranded DNA; (lane 6) ampification of material eluted
from beads (desired product containing one long and one short adaptor); (lane 7) negative PCR control.
Figure 2. Schematic of bioinformatic analysis applied to BRISK se-
quencing results. (ED) Levenstein edit distance.
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amplification or sequencing error. We were thus able to assign
99.36% of tags from the human blood sample to human origin. The
origin of the remaining tags is not known but may represent addi-
tional, individual polymorphism as has recently been described for
human Alu sequences (Hormozdiari et al. 2011). Estimation of se-
quencing error was accomplished by analyzing known, single-fre-
quency human BsaX1 sites and comparing recovered tags from an
aseptically obtained human blood sample to reference human se-
quences. Levenshtein edit distance for each recovered tag from the
reference tag was calculated, and the mode frequency for each
known single-frequency site was considered as sample normative to
account for polymorphisms. Deviations from normative frequency
were then calculated and averaged across all sites. Based on this
analysis, we estimate that sequencing error accounts for <1% of
assignment of nonhuman tags. In total, 78.8% of all predicted hu-
man tags were recovered. Each predicted tag was recovered, on av-
erage, 5.51 times. The distribution of quantitative tag recovery for
single-frequency tags is shown in Supplemental Figure 1A. Com-
parison of number of observed tags vs. expected tags by chromo-
some revealed very high correlation (Table 2; Fig. 3; r2 = 0.999).
Mapping of individual tags to chromosome locations revealed
a normalXYkaryotype (Supplemental Fig. 2). No tagsmet criteria for
match to microbial sequence. Eight tags were found to match viral
sequences: six tags unique for human endogenous retrovirus H, and
two tags unique for human endogenous retrovirus K.
Application to linearly amplified DNA
To determine whether the BRISK technique could be used effec-
tively with small amounts of DNA amplified by linear, multiple
displacement (phi29) amplification (Leviel et al. 2004; Bredel
et al. 2005), we amplified 1 ng of the blood-derived human ge-
nomic DNA to yield 1 mg of total material. 4,091,327 tags were
recovered from amplified material, of which 3,868,735 (95%)
were perfect matches for human sequence (Table 1). 50.0% of all
human tags were recovered. Comparison of the human karyotype
of amplified and unamplified DNA demonstrated a high degree of
linearity of the amplified material, although tag recovery was not
as perfectly linear as with unamplified material (Fig. 3). Re-
gression analysis revealed very high correlation coefficients for
observed vs. expected tag counts per chromosome (r2 = 0.976 for
amplified material). The distribution of recovered single-copy
tags did not reveal significant skewing relative to BRISK analysis
of nonamplified material (Supplemental Fig. 1B). Karyotype
analysis of amplified material showed no artifactual amplifica-
tions or deletions (Supplemental Fig. 3). No microbial sequences
were recovered. Three tags were recovered for human endogenous
retrovirus H. These results suggest that genomic DNA samples as
small as 1 ng can be effectively analyzed with near-quantitative
recovery of tags by BRISK.
Application to biome characterization
The sensitivity of BRISK for detection
of nonhuman DNA was tested by spiking
a human blood sample with purified
Escherichia coli genomic DNA. 1mg of
human blood DNA was combined with
20 pg of E. coli DNA (1:50,000 by weight,
;1% by molar genome). As this sample
was analyzed in multiplex (using a 2-bp
bar code embedded in the adaptor), fewer
total tags were recovered. Of the 681,325
tags recovered, 2104 (0.3%) were found to be perfect matches for
E. coli. Of the 988 potential distinct E. coli sequence tags, 464 were
recovered. No other tags meeting criteria for any other microbial
genome were identified.
We proceeded to characterize the biome of the oral mucosa
using BRISK to determine its ability to identify the organisms found
in a complex host microbial environment. DNAwas obtained from
buccal brushings of two individuals and amplified with phi29
methodology. The first sample yielded 3,400,930 tags, of which
2,523,611 (74%) were human (Table 1). One percent, or 37,874
tags, were perfect matches for the microbial database, while
839,445 (25%) matched neither human sequence nor known mi-
crobial or viral sequence. In the second sample, 3,896,003 tags
were recovered, of which 1,581,395 (41%) were of human origin
(Table 1). There were 112,202 tags (3%) which were perfect matches
for microbial or viral sequences, and 2,202,406 (57%) sequences
matched neither human nor microbial/viral databases. Human
karyotypes for both samples were highly linear suggesting quanti-
tative recovery of human DNA (data not shown).
We considered amicrobial species to be identified when two or
more tagsunique in thedatabase to that specieswere recovered in an
individual’s buccal mucosa sample. None of the putative microbial
matches were found in BRISK analysis of blood, HEK293, SW480, or
HT-29 human cell lines (data not shown), suggesting that these are
Table 1. BsaXI tag recovery by experiment
Sample
Phi29
amplified Total tags Human
Microbial
matches Unknown
Human blood No 12,529,752 11,844,721 (95%) 8 (viral) (0%) 685,023 (5%)
Human blood
(phi29 amplified)
Yes 4,091,327 3,868,735 (95%) 3 (viral) (0%) 222,589 (5%)
Buccal sample 1 Yes 3,400,930 2,523,611 (74%) 37,874 (1%) 839,445 (25%)
Buccal sample 2 Yes 3,896,003 1,581,395 (41%) 112,202 (3%) 2,202,406 (57%)
Nasopharyngeal
carcinoma slide
Yes 3,196,086 1,970,031 173,974 (5%) 1,052,081 (33%)
Table 2. Expected and recovered BsaXI tags per human
chromosome from human blood sample by BRISK
Chromosome BsaXI sites Obtained tags Fold coverage
1 87,161 804,023 9.225
2 84,481 766,541 9.074
3 67,034 608,038 9.071
4 56,483 493,753 8.742
5 59,462 531,790 8.943
6 57,599 513,989 8.924
7 53,411 482,168 9.028
8 50,748 458,119 9.027
9 41,938 377,088 8.992
10 49,724 449,742 9.045
11 51,136 466,689 9.126
12 47,363 428,804 9.054
13 30,671 276,701 9.022
14 32,461 295,323 9.098
15 30,618 280,307 9.155
16 32,319 300,618 9.302
17 34,930 325,020 9.305
18 26,405 238,530 9.034
19 27,487 256,823 9.343
20 27,566 258,565 9.380
21 12,295 111,352 9.057
22 17,444 166,189 9.527
X 42,375 194,271 4.585
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bona fide microbial sequences and not contaminant sequences
or sequences shared between human and microbial genomes. Or-
ganisms corresponding to recovered tags found in both individuals’
oralmucosa are shown in Table 3. A total of 29 species were identified
in common from both patients’ samples. Sequences from Streptococ-
cus species were the most commonly recovered and accounted for
57.5% and 90.7% of all microbial tags
recovered in the individual samples, re-
spectively. Eighteen genera in total were
identified. All have been previously iden-
tified in large-scale, deep sequencing of
16S DNA of the oral mucosa (Keijser et al.
2008; Nasidze et al. 2009a; Nasidze et al.
2009b; Zaura et al. 2009). While the ma-
jority of species were found in both in-
dividuals’ samples, significant differences
in quantitative recovery were found. In
particular, Veillonella parvula, a gram-nega-
tive, anaerobic bacterium found as com-
mensal in multiple human mucosal sites,
accounted for 22.5% of tags in the first
sample, but only 3.4% of tags in the sec-
ond. A total of eight species were detected
in only one individual’s saliva, the most
prevalent being Streptococcus parasanguinis,
which constituted 6.1% of recovered tags
from the first subject’s sample but was not
found in the second subject.
In both samples, the majority of ap-
parent nonhuman tags were not found
in the NCBI database (25% and 57% of
total tags, respectively). We selected the
20 most abundantly recovered unknown
tags found in saliva of one individual but
not blood or cell line DNA for further
analysis. Using the vectorette genomic
DNA walking technique (Ko et al. 2003),
we successfully generated additional ge-
nomic sequence ranging from 298 to 991
bp from eight of these tags (Supplemental
Table 1). Analysis against the NCBI data-
base revealed that all but one tag were
unique and novel sequences in the non-
redundant DNA database. We termed
these sequences Genome Unknown Sequences (GUS). The eighth
tag was found to be from a human gene sequence identified in a
genome build subsequent to the build utilized in our bioinformatic
software. To identify possible organisms accounting for these se-
quences, a translated BLAST search was performed for each se-
quence. While only GUS 3 was a near-perfect match (for Haemo-
philus influenza), five of the six remaining GUS tags yielded high
probability matches (Table 3). All were homologous to microbially
derived sequences, including two phage sequences [GUS 4 for a
Streptococcus pyogenes phage (E value 2 3 1024) and GUS 7 for an
Actinomycesphage (E value 53 1014) (Table 4)].Wegeneratedunique
PCR primers for the novel sequences, targeting sequences outside
the original BsaXI tag. As shown in Figure 4, three tag sequences
(GUS2, 3, and6)were found in saliva of all individuals but not found
in blood or HEK293 cell line DNA. The remaining three GUS tags
appeared unique to the individual in whom they were identified.
Application to pathogen detection in carcinoma
One of the attractive features of digital karyotyping in pathogen
detection and discovery is the ability to find potential pathogens
associated with specific disease conditions. Most cases of naso-
pharyngeal carcinoma are associated with Epstein-Barr virus (EBV,
HHV-4), which is thought to be causative of disease (Thompson
Figure 3. Observed vs. expected recovery of sequence tags by chro-
mosome using BRISK from human whole blood sample. (Closed circles)
unamplified DNA; (open circles) phi29 amplified DNA.












Streptococcus mitis 22.55 43.12 X X
Streptococcus pneumoniae 21.61 42.15 X X
Streptococcus sanguinis 3.49 3.70 X X
Veillonella parvula 22.53 3.42 X X
Fusobacterium nucleatum 9.46 1.98 X X
Streptococcus gordonii 3.63 1.31 X X
Haemophilus influenzae 0.18 1.00 X X
Aggregatibacter aphrophilus 0.12 0.85 X
Rothia mucilaginosa 0.12 0.84 X X
Haemophilus somnus 0.20 0.39 X X
Leptotrichia buccalis 2.29 0.36 X X
Streptococcus agalactiae 0.04 0.21 X X
Streptococcus oralis 0.19 0.18 X X
Neisseria meningitidis 0.13 0.07 X X
Capnocytophaga ochracea 3.75 0.07 X X
Streptococcus dysgalactiae 0.01 0.03 X X
Streptococcus thermophilus 0.04 0.02 X X
Actinobacillus pleuropneumoniae 0.01 0.02 X X
Atopobium parvulum 0.88 0.02
Porphyromonas gingivalis 1.87 0.02 X X
Bacteroides fragilis 0.07 0.02 X
Treponema denticola 0.10 0.01 X X
Campylobacter concisus 0.03 0.01 X X
Fusobacterium periodonticum 0.01 0.01 X X
Bacteroides thetaiotaomicron 0.04 0.01 X
Clostridium difficile 0.19 0.01 X X
Enterococcus faecalis 0.03 0.00 X
Granulicatella adiacens 0.01 0.00 X
Streptobacillus moniliformis 0.05 0.00 X X
Streptococcus parasanguinis 6.11 X X
Aggregatibacter actinomycetemcomitans 0.26 X X
Streptococcus vestibularis 0.01 X X
Prevotella nigrescens 0.05 X X
Clostridiales genomosp. 0.02
Lactobacillus salivarius 0.01 X X
Streptococcus equi 0.01 X X
Lactobacillus fermentum 0.00 X X
Biome representational in sil ico karyotyping
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and Kurzrock 2004). To determine if BRISK has adequate sensitivity
to detect a virally mediated carcinoma, we subjected two fixed,
parafin-embeddedmicroscope slides of a nasopharyngeal carcinoma
specimen to themethod following phi29 amplification of recovered
DNA. A total of 1,970,031 human sequences were recovered. Of
these, there were 81,799 tags (4.1%) which were perfect matches for
HHV-4. Additionally, 16, 826 tags were recovered that were perfect
matches for either Delftia acidovorans, Stenotrophomonas maltophilia,
Propionibacterium acnes, or Cupravidus metalidurans. It is assumed
that the latter were bacterial contaminants found on the surface of
the pathology specimen slides.
Discussion
The characterization of the humanmicrobiome is important for the
understanding of disease. Various sites in the human body house
trillions of microbes, phages, and viruses, whose presence may be
essential to development of diseases such as Type I diabetes (Wen
et al. 2008), obesity (Turnbaugh et al. 2009), and cancer (Lampe
2008). Individual sites such as the oral mucosa, intestinal tract, and
skin harbor uniquemicrobiomes that vary between individuals and
change over time (Turnbaugh et al. 2009). Numerous potential
pathogens are also part of the normal commensal flora.Methods for
characterization of the human microbiome have included large
scale ‘‘universal’’ 16S (bacterial) and 5.8 S and 28S (fungal) DNA
sequencing (for review, see Petrosino et al. 2009), array-based tech-
niques for detection of viral sequences (Wang et al. 2002a; Palacios
et al. 2007), large scale shotgun sequencing (Qin et al. 2010), and
shotgunproteomics (Verberkmoes et al. 2009). These techniques are
all powerful methods for determination of the members of a micro-
biome community, but all make significant assumptions about the
nature of members (i.e., bacterial, fungal, viral).
Large scale saturation shotgun DNA sequencing of complex
biomes (Venter et al. 2004) represents the gold standard for char-
acterization of DNA-based life forms but is extremely resource-in-
tensive and not practical at present for use on individual human
subject or patient samples. Digital karyotyping techniques (Wang
et al. 2002b; Tengs et al. 2004) represent an approximation of total
shotgun sequencing, in which a defined representation (in our
case, 27-bp sequence per 4096-bp average for 6-bp recognition site,
or 0.66%of total genome) can be sequenced to near-saturation. This
technique has recently been used to identify microbial sequences
associated with human cancers (Duncan et al. 2009) but has not
been previously used to characterize complex microbiomes.
The BRISK technique represents a conceptual extension of the
RECORDmethod (Tengs et al. 2004), allowing specific amplification
of Type IIB endonuclease restriction frag-
ments without cloning and direct appli-
cation of these fragments to a massively
parallel DNA sequencing platform. The
technique may be performed as described
on very small amounts of material (on the
order of 1 ng starting genomic DNAwhen
phi29 amplification is employed). The
technique is quite rapid, requiring ;6 h
from sample acquisition to initiation of
DNA sequencing. Because the representa-
tion is defined by the BsaXI restriction site,
all known human, microbial, viral, fungal,
and parasitic tags can be a priori predicted,
allowing for very rapid bioinformatics
analysis; complete analysis of samples con-
taining >106 sequence tags can be completed in ;15 min on a
standard desktop personal computer. Because of the large number
of tags generated in this technique, resolution of the digital kar-
yotype approaches the theoretical limit of 4 kb and allows precise
mapping of amplifications and deletions.
We chose to examine the oral mucosa using BRISK, as this is
a relatively well-characterized site with respect to bacterial flora. The
BRISK analysis was able to identify nearly 30 species in common
between two individuals. The genera identified have all been pre-
viously identified in large-scale studies as present in normal
oral mucosa and constitute the majority of previously identified
species. BRISK analysis of the oral microbiome suggests that greater
than 90% of nonhuman sequences in the mouth have not been
previously sequenced in any context. Some of these sequences un-
doubtedly belong to species whose 16S or other sequences are
known. Interestingly, however, when we examined seven of the
most prevalent of these sequences by chromosome walking, the
majority of sequences remained uncharacterized. Conceptual
translation of these sequences revealed only one candidate likely to
be a direct match for a known microbe. Two of the six remaining
sequences appear to be phage-derived. With the recent suggestion
that a phagemay be a determinant of pathogenicity in diseases such
Table 4. Translated BLAST matches for prevalent GUS sequences




















+2 69% 81% 2 x 1024
5 Transcription regulator Streptococcus gordonii str.
Challis substr. CH1
3 69% 83% 3 x 1047
6 No match
7 Terminal protein Actinomyces phage Av-1 +2 30% 54% 5 x 1014
Figure 4. Distribution of genomically unknown sequences (GUS) in
the oral mucosa of three normal human volunteers. PCR primers were
designed for each of eight GUS tags and performed on salivary DNA
samples from three individuals (S1–S3). S1 was the individual fromwhom
each GUS was originally identified. (B) is PCR performed on blood-
derived DNA from subject 1; (C) is PCR performed on DNA derived
from HEK293 cells. (NC) is a no-template DNA negative control. Uni-
versal bacterial 16S primers were used as positive control for the presence
of bacterial DNA. Melanopsin (OPN4)-specific primers were used as
positive control for the presence of humanDNA. After sequence extension
by vectorette-assisted genome walking, GUS 8 was identified as a human
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as meningitis (Bille et al. 2008), means to detect such sequences may
be of importance (Tinsley et al. 2006).
The BRISK method does have limitations for the characteriza-
tion of complex biomes. As a DNA-based technique, BRISK cannot
detect RNA viruses or microRNA signatures without modification
(i.e., reverse transcription). The sensitivity for detection of foreign
DNA with BRISK is dependent on the relative abundance of the
foreign organism and its genome size, making very small foreign
genomes [such as the polyoma virus responsible for Merkel cell tu-
mors (Feng et al. 2008)] difficult to detect. Similarly, although BRISK
provides some quantitative information on abundance in the form
of ‘‘tag counts,’’ knowledge of the relative genome size is required for
more precise quantitation. Finally, BRISK does require use of a mas-
sively parallel DNA sequencing apparatus, whichmay not be readily
available.
Despite these limitations, BRISK represents a rapid and highly
sensitivemethod for characterization of complex microbiomes, in
addition to being a sensitive means for performing digital kar-
yotyping. With new sequence information arising from human
microbiome research, the utility of this approach will increase.
BRISK will be well-suited to analysis of particular microbiomes over
time, as analyses are directly comparable fromone time point to the
next; such analysis would likely be more efficient and cost-effective
than repeated deep sequencing, for example. BRISK should find




DNAwas collected from venous blood and buccal swabs of healthy
volunteers. This studywas performedwith informed consent, under
Institutional Review Board approval of the Washington University
Medical School and University of Washington Medical School.
Preparation of genomic DNA
Genomic DNA (gDNA) was extracted from the HEK293T cell line
(ATCC, CRL-11268) and E. coli (Invitrogen) using the DNEasy Blood
and Tissue kit (Qiagen). Human blood gDNA was extracted using
the Paxgene kit (Qiagen), and gDNA from buccal brushings was
harvested using the Purgene C kit (Qiagen). The gDNA was eluted
into deionized, distilled water (ddH2O). 3 mg gDNA was used for
each analysis.
BsaXI digest of gDNA
After extraction, the gDNA was digested using a type IIB re-
striction endonuclease, BsaXI (New England Biolabs), using the
manufacturer’s recommended buffer and reaction conditions at
37°C for 16 h.
Preparation of adaptors
Adaptors complementary to the solid-phase bridge oligonucleotides
on the Illumina Genome Analyzer’s flow cell were synthesized and
purified by high-performance liquid chromatography (Integrated
DNA Technologies). The longer adaptor was 59-AATGATACGGCG
ACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGAT
CTMMNNN-39, where theMM represents two pre-determined bases
(AA, TT, CC, GG) used as the barcode for multiplex sequencing, and
NNN represents a 59 degenerate overhang to hybridizewith the 3-bp
39 overhang on the restriction fragment. The complement for this
adaptorwas 59-MMAGATCGGAACAGCGTCGTGTAGGGAAAGAGT
GTAGATCTCGGTGGTCGCCGTATCATT-39.
The shorter tag was biotinylated: 59-Bio-CAAGCAGAAGACGG
CATACGAGCTCTTCCGATCNNN-39. The complement to this adap-
tor was 59-CTAGCCTTCTCGAGCATACGGCAGAAGACGAAC-39.
The adaptors were reconstituted in ddH2O to create a 10 mM
solution. The adaptors were annealed by placing the equimolar
mix in a boiling-water bath for two minutes, then removing the
bath from the heat source and allowing to cool to room tempera-
ture (;3 h). The double stranded adaptors were diluted in 13 TE to
a working solution of 1 mM.
Ligation of adaptors to BsaXI restriction fragments
Restriction fragments were ligated to the adaptors using T4 DNA
ligase (New England Biolabs) under standard conditions, modified
by additional ATP (Sigma-Aldrich) at 1 mM. Ligation was carried out
at 4°C for 1 h.
Separation of products on a biotin-streptavidin column
The ligated tags were separated on a Dynabead column (Invitrogen)
usingmagnetic stand (Invitrogen) to isolate the asymmetric ligation
product of interest. First, the beads were washed twice with 23
binding and wash buffer (10 mM Tris-HCl at pH 7.5; 1mM EDTA;
2M NaCl). The beads were resuspended in a half-volume of 23
binding and wash buffer, and the ligation product was added to the
column. After shaking on a horizontal rotator for 20 min, the su-
pernatant was removed, and the beads were washed twice with 13
binding and wash buffer.
Nick-translation using Bst DNA polymerase
Boundproductswere incubatedwith0.4mMdNTPs (Sigma) andBst
DNA polymerase (New England Biolabs) under the manufacturer’s
recommended conditions. After shaking at 65°C for 20 min, the
supernatant was removed, and the beads were washed twice with
13 binding and wash buffer.
Collection of the ssDNA library containing the asymmetric
product of interest
To remove the product of interest (i.e., 33-bp tag with one short
and one long adaptor ligated), ssDNAwasmelted from the column
using a solution of 100 mM NaCl and 125 mM NaOH. After ad-
dition of the melt solution, the column was shaken on a vertical
rotator for 10 min. The supernatant was removed on the magnet
and neutralized using an equal volume of a neutralization solution
made of buffer PBI from theQiaquick PCR purification kit (Qiagen)
and 0.15% acetic acid.
PCR amplification of the ssDNA library
Toamplify theproduct of interest, PCRusingPhusionTaq (Finnzymes)
was performed. The sequence of the 59 primer for this reaction was:
59-AATGATACGGCGACCACCGAGATCT-39; the sequence of the
39 primer for this reaction was: 59-CAAGCAGAAGACGGCATAC
GAGCTCTTCCGATC-39. The PCR was performed using a rapid
cycling method with 25 cycles of: 94°C for 30 sec and 72°C for 15
sec. To prepare samples for high-throughput sequencing, ten iden-
tical PCR products were combined and purified using the Qiaquick
PCR purification kit (Qiagen).
Bioinformatic analysis of sequencing results
All available human and microbial genomes from NCBI were
downloaded in Feb. 2007 and virtually digested with the BsaXI
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restriction enzyme to produce a library of 33-bp tags mapped to
their respective sources and locations. To analyze the sequencing
information, raw sequences that matched the restriction enzyme
sitewere identified andonly tags that appearedmore than oncewere
analyzed. The 27 bp surrounding theDNA recognition sequencewas
used for analysis. The resulting tags were filtered against the library
of tags from thehumangenomeby finding the shortest edit distance
(ED) from each sample tag to the library tag. Based upon an empir-
ically-derived, distribution-based analysis, a cutoff of 3 ED was used
to classify a tag as amatch to the human genome. All remaining tags
were similarly matched against all sequenced bacterial, viral, and
fungal genomes that were present in the nonredundant NCBI da-
tabase. Individual tags that were 3 ED from the nearest known ge-
nomes were classified as a ‘‘genomically unknown sequence’’ (GUS).
GUS tags were then BLAST-searched against the entire NCBI non-
redundant database. For tags matching sequences in the microbial
database, analysis was performed at the level of genus, as many
subspecies of particular microbial genera had identical tags.
The frequency of the tag in the sample (observed) was divided
by the frequency of the tag in the virtually digested human genome
(expected); this value was rounded to the nearest whole number
to create a score for each organism in the sample. For in silico
karyotyping, single-frequency human library tags unique to each
chromosome were identified. Chromosome distribution maps
were generated by dividing observed tag density over expected
tag density per contiguous 1000 unique tags.
Perl source code for all analysis software used in this study is
available from the corresponding author.
Genome-walking protocol to extend GUS tags
A vectorette protocol (Ko et al. 2003) was used to find adjacent se-
quence to GUS tags. Vectorette libraries of phi29 amplified buccal
mucosalDNA from theoriginal samplewere constructed using eight
restriction enzymes (BglII, BclI, BstBI, BsaHI,XbaI, SpeI,MfeI, EcoRI;
New England Biolabs). The restriction products were ligated to
vectorette adaptors annealed to an imperfect complement that
created a bubble structure in each adaptor. The four types of vec-
torette adaptorswere complementary to the four types of overhangs
created by the restriction enzymes. The sequence for the four vec-
torette adaptors were as follows:













Before ligation, the adaptors were mixed with the restriction prod-
ucts at a final concentration of 0.02 mM and incubated at 65°C for 5
min. To ensure optimal annealing, the block containing sampleswas
removed from the heat source and allowed to cool to room tem-
perature and then placed at 4°C for 1 h. Subsequently, the T4 DNA
ligase (New England Biolabs), T4 DNA ligase buffer (New England
Biolabs), and 10 mM ATP (Sigma-Aldrich) were added, and the re-
action was incubated at 16°C overnight.
After construction, the DNA library was used for PCR with
primers to the unique GUS tag and primers to the vectorette adap-
tors at a final concentration of 0.25 mM. HotStarTaq (Qiagen) was
used under standard conditions in a step-down PCR. Three samples
of each DNA digest in the library were run at a low, medium, and
high temperature during each anneal step to determine if bands
were true products or secondary to PCR artifacts. The temperature
conditions for the PCR were 95°C for 14 min; denaturing at 95°C
for 1 min, annealing across a gradient of 63–72°C for 1 min, exten-
sion at 72°C for 2 min for 5 cycles; denaturing at 95°C for 1 min,
annealing across a gradient of 59–68°C for 1 min, then extension at
72°C for 2min for 5 cycles; denaturing at 95°C for 45 sec, annealing
across a gradient of 55–64°C for 1 min, then extension at 72°C for
2 min for 10 cycles; denaturing at 95°C for 45 sec, then annealing
across a gradient for 51–60°C for 1 min, then extension at 72°C for
2 min for 10 cycles; final extension was done at 72°C for 10 min.
Products from this PCR were separated on a 2% Tris-Acetate-
EDTA agarose gel, and bands appearing across all annealing tem-
peratures for a particular set of DNA in the library were extracted
using the DNA Clean and Concentrator (Zymo Research). These
products were transformed and cloned using the Topo TA pCR 2.1
kit (Invitrogen). Cloned plasmids were extracted using the Qiaprep
SpinMiniprep Kit (Qiagen), and the DNAwas subjected to standard
dye-terminator sequencing.
Confirmation of sequences obtained from genome walking
To confirm that sequences extracted by genome walking were pres-
ent in the sample, PCR primers were designed outside the original
tag sequence and used to amplify the initial DNA sample. The PCR
used Fisher Bioreagents Taq DNA polymerase (Fisher) under stan-
dard conditions. The temperature conditions for the PCR were 94°C
for 2 min; denaturing at 94°C for 30 sec, annealing at a temperature
determinedbyprimerTm for 30 sec, and extension at 72°C for 30 sec
for 20 cycles, and then a final extension at 72°C for 5 min.
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